Health policy or intellectual property policy? The fight over Bill C-91. Canadian Healthcare Association.
Adapted from the Canadian Healthcare Association's submission to the House of Commons Standing Committee on Industry currently reviewing Bill C-91, an Act to amend the Patent Act. Discusses the controversy surrounding this legislation, which extended patent protection to brand-name drug manufacturers to 20 years before generic copies of pharmaceuticals can be introduced on to the market.
D002170:Canada; D017277:Drug Approval; D004341:Drug Evaluation; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000600:supply & distribution*; D006291:Health Policy / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D013995:Time